Talha Badar
0000-0003-1548-918X
Mayo Clinic
25 papers found
Refreshing results…
TP53 variant allele frequency and therapy‐related setting independently predict survival in myelodysplastic syndromes with del(5q)
Updates on risk stratification and management of lower-risk myelodysplastic syndromes/neoplasms
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Outcomes of allogeneic transplant in patients with DDX41 mutated myelodysplastic syndrome and acute myeloid leukemia
Clinical outcome of myelodysplastic syndrome progressing on hypomethylating agents with evolving frontline therapies: continued challenges and unmet needs
Real‐world experience with venetoclax and hypomethylating agents in myelodysplastic syndromes with excess blasts
Real‐world experience with luspatercept and predictors of response in myelodysplastic syndromes with ring sideroblasts
Prospect of CAR T-cell therapy in acute myeloid leukemia
Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms
Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy
Do histone deacytelase inhibitors and azacitidine combination hold potential as an effective treatment for high/very-high risk myelodysplastic syndromes?
Multi-institutional study evaluating clinical outcome with allogeneic hematopoietic stem cell transplantation after blinatumomab in patients with B-cell acute lymphoblastic leukemia: real-world data
Sequencing of novel agents in relapsed/refractory B‐cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemia
Delayed neurotoxicity after axicabtagene ciloleucel therapy in relapsed refractory diffuse large B-cell lymphoma
Clinical activity of ibrutinib in classical Hodgkin lymphoma relapsing after allogeneic stem cell transplantation is independent of tumor BTK expression
Interrogation of molecular profiles can help in differentiating between MDS and AML with MDS-related changes
Trends in postrelapse survival in classic Hodgkin lymphoma patients after experiencing therapy failure following auto-HCT
African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States
Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with Inotuzumab Ozogamicin
Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with Blinatumomab
Missing publications? Search for publications with a matching author name.